Natural History of Atherosclerosis
Related Articles
- A Prospective Natural-History Study of Coronary Atherosclerosis. // New England Journal of Medicine;11/24/2011, Vol. 365 Issue 21, p2040
A correction to the article "A Prospective Natural-History Study of Coronary Atherosclerosis" that was published in the 2011 issue is presented.
- Cardiovascular Risk Factors in Children (Book Review). Lloyd, June K. // British Medical Journal (Clinical Research Edition);2/7/1981, Vol. 282 Issue 6262, p469
Reviews the book 'Cardiovascular Risk Factors in Children: The Early Natural History of Atherosclerosis and Essential Hypertension,' by Gerald S. Berenson.
- Atherosclerosis in youth: are hypertension and other coronary heart disease risk factors already at work? Oalmann, Margaret C.; Strong, Jack P.; Tracy, Richard E.; Malcom, Gray T. // Pediatric Nephrology;1997, Vol. 11 Issue 1, p99
The purposes of this review were to describe the natural history of atherosclerosis in youth, discuss the role of adult coronary heart disease (CHD) risk factors in the development of atherosclerosis — particularly in the young — and present the relationship between atherosclerosis...
- Medical Perspectives in Coronary Artery Surgery -- A Caveat. Dunkman, W. Bruce; Perloff, Joseph K.; Kastor, John A.; Shelburne, James C. // Annals of Internal Medicine;Dec74, Vol. 81 Issue 6, p817
Presents a review of evidence on the history of surgery for, and the natural history of, symptomatic coronary atherosclerosis. Criteria for measuring the effects of surgery; Considerations in selection for surgery; Conclusions and recommendations.
- Renal-Artery Stenosis. Safian, Robert D.; Textor, Stephen C. // New England Journal of Medicine;02/08/2001, Vol. 344 Issue 6, p431
Discusses renal-artery stenosis. Prevalence and natural history of fibromuscular dysplasia and atherosclerosis; Discussion of renovascular hypertension and ischemic nephropathy; Diagnosis; Treatments, including medical therapy and surgical and percutaneous revascularization.
- Failed Angioplasty of a Popliteal Artery Stenosis Secondary to Cystic Adventitial Disease. Khoury, Michael // Vascular & Endovascular Surgery;May/Jun2004, Vol. 38 Issue 3, p277
The purpose of this case review is to describe treatment options for arterial occlusive disease secondary to a popliteal cyst. The occurrence of this disease is significantly less than atherosclerosis as the cause of claudication. The clinical presentation, natural history, and treatment options...
- High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN. Diabetes Care 2014;37:3114-3120. Bao-Tao Huang; Mao Chen // Diabetes Care;Feb2015, Vol. 38 Issue 2, pe27
A letter to the editor is presented in response to the article "High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN," by Stegman and colleagues in issue number 2014; 37: 3114-3120.
- Arteries too good to kill. McGill Jr., Henry C. // JAMA: Journal of the American Medical Association;1/26/94, Vol. 271 Issue 4, p317
Editorial. Discusses various aspects of coronary heart disease. Discovery of various aspects of hyperlipidemia; Lipoprotein's similarity to plasminogen; Structure and function of the arterial wall; Natural history of atherosclerosis; Use of coronary angiography to assess the effectiveness of...
- ATHEROSCLEROSIS SUBLUXATION MEDICARE. Seaman, David // ACA News (American Chiropractic Association);Jun/Jul2015, Vol. 11 Issue 5, p16
The article discusses the documentation of chiropractic services for atherosclerosis and subluxation under Medicare. Topics include the association between metabolic syndrome and atherosclerosis, the changes in the perception about the nature of atherosclerosis and the definition of subluxation...
- Effect of Doxycycline on Atherosclerosis: From Bench to Bedside. Rodriguez-Granillo, Gast�n A.; Rodriguez-Granillo, Agustina; Milei, Jos� // Recent Patents on Cardiovascular Drug Discovery;Jan2011, Vol. 6 Issue 1, p42
Matrix metalloproteinases (MMPs) have a pivotal role in the natural history of atherosclerosis and its cardiovascular consequences. Non-selective MMP inhibition with doxycycline appears as a potential strategy to reduce the residual risk observed in patients already at intensive lipid lowering...
